# EDGAR Filing Document

**Accession Number:** 0001554859
**File Stem:** 0001104659-25-082514
**Filing Date:** 2025-8
**Character Count:** 3735
**Document Hash:** 5fae76b8d44436428f86e69def5470d9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-082514.hdr.sgml**: 20250825

**ACCESSION NUMBER**: 0001104659-25-082514

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20250825

**DATE AS OF CHANGE**: 20250825

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Semler Scientific, Inc.
- **CENTRAL INDEX KEY:** 0001554859
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 261367393
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36305
- **FILM NUMBER:** 251250894

**BUSINESS ADDRESS:**
- **STREET 1:** 51 E CAMPBELL AVE
- **STREET 2:** SUITE 107-D
- **CITY:** CAMPBELL
- **STATE:** CA
- **ZIP:** 95008
- **BUSINESS PHONE:** 8777744211

**MAIL ADDRESS:**
- **STREET 1:** 51 E CAMPBELL AVE
- **STREET 2:** SUITE 107-D
- **CITY:** CAMPBELL
- **STATE:** CA
- **ZIP:** 95008

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**SCHEDULE 14A INFORMATION**

**Proxy Statement Pursuant to Section 14(a) of the <br> Securities Exchange Act of 1934**

**(Amendment No.)**

Filed by the Registrant ⌧

Filed by a Party other than the Registrant ◻

Check the appropriate box:

---

| | |
|:---|:---|
| ◻ | Preliminary Proxy Statement |
| ◻ | **Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))** |
| ◻ | Definitive Proxy Statement |
| ⌧ | Definitive Additional Materials |
| ◻ | Soliciting Material under §240.14a-12 |

---

**SEMLER SCIENTIFIC, INC.**

(Name of Registrant as Specified in Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

---

| | |
|:---|:---|
| ⌧ | No fee required. |
| ◻ | Fee paid previously with preliminary materials. |
| ◻ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |

---

**SUPPLEMENT TO THE PROXY STATEMENT**

**FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON**

**SEPTEMBER 5, 2025**

This proxy statement supplement dated August 25, 2025 amends and supplements the definitive proxy statement on Schedule 14A, or the Proxy Statement, filed by Semler Scientific, Inc., or Semler Scientific, with the Securities and Exchange Commission, or SEC, on July 17, 2025, for Semler Scientific's 2025 Annual Meeting of Stockholders, or the Annual Meeting. The Annual Meeting will be held virtually via live webcast at a unique link to be received after registering at https://web.viewproxy.com/Semler/2025. This supplement should be read in conjunction with the Proxy Statement. Other than as set forth below, no changes have been made to the Proxy Statement.

**Adjournment**

If there is no quorum, the chairman of the meeting may adjourn the annual meeting to another date. In addition, the chairman may adjourn the annual meeting, if necessary, to a later date or dates to permit further solicitation and votes of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the proposals described in the Proxy Statement. Our bylaws provide that any annual meeting of stockholders may be adjourned from time to time either by the chairperson of the meeting or by the vote of the holders of a majority of the voting power of the shares present in person, by remote communication, if applicable, or represented by proxy duly authorized at the meeting and entitled to vote thereon.

**Social Media Posts**

![](tm2524322d1_def14aimg001.jpg)

![](tm2524322d1_def14aimg002.jpg)